HomeAVIR • NASDAQ
add
Atea Pharmaceuticals Inc
Previous close
$5.91
Day range
$5.85 - $6.07
Year range
$2.46 - $6.45
Market cap
478.03M USD
Avg Volume
599.46K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.12M | -46.72% |
Net income | -44.87M | -33.76% |
Net profit margin | — | — |
Earnings per share | -0.57 | -42.50% |
EBITDA | -54.61M | -58.74% |
Effective tax rate | 13.11% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 301.83M | -33.62% |
Total assets | 315.22M | -32.16% |
Total liabilities | 39.78M | 54.20% |
Total equity | 275.43M | — |
Shares outstanding | 79.67M | — |
Price to book | 1.67 | — |
Return on assets | -41.56% | — |
Return on capital | -46.12% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -44.87M | -33.76% |
Cash from operations | -28.22M | 7.15% |
Cash from investing | 46.59M | 1,482.55% |
Cash from financing | 0.00 | — |
Net change in cash | 18.37M | 154.40% |
Free cash flow | -12.24M | 29.26% |
About
Founded
2012
Headquarters
Website
Employees
55
